Yves Bonhomme
Direktor/Vorstandsmitglied bei Bellus Health (Innodia), Inc.
Profil
Yves Bonhomme is a Director of Innodia, Inc. Prior to joining Innodia, he was Managing Director and Head of Research and Development for Lipha SA until 2002 and Chairman of Lyon University School of Pharmacy from 1997 to 2001.
Dr. Bonhomme has diabetes research and product development experience.
He received an undergraduate degree from INSEAD.
Aktive Positionen von Yves Bonhomme
| Unternehmen | Position | Beginn |
|---|---|---|
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Yves Bonhomme
| Unternehmen | Position | Ende |
|---|---|---|
| University of Lyon | Corporate Officer/Principal | 01.01.2001 |
Ausbildung von Yves Bonhomme
| INSEAD | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |